22 to 30 December 2014 Vol. No. 45 Issue No. 48 01 to 07 August

Vol. No.
No. 45
Vol.
44
Vol. No.43
43
44
Founder
FounderEditor:
Editor:
Founder
Dr.
Dr.A.
A.Patani
Patani
A.
Editor:
Editor:
Editor:
Dr.
Dr.Gopakumar
GopakumarG.
G.Nair
Nair
Dr.
Gopakumar
Nair
Associate
Associate
Editors:
AssociateEditors:
Editors:
J.L.
Sipahimalani
J.L.Sipahimalani
Sipahimalani
J.L.
Dr.
Dr.Nagaraj
NagarajRao
Rao
Dr.
Nagaraj
Rao
Dr.
Dr.George
GeorgePatani
Patani
George
Patani
President
President
Manish
U.
Manish
U.Doshi
Doshi
S.
V. Veerramani
Immediate
Past
President
Immediate
Past
President
Immediate
Past
President
N.R.
N.R.Munjal
Munjal
Manish U. Doshi
Vice-Presidents
Vice-Presidents
Vice-Presidents:
Vice-Presidents:
Vice-Presidents:
(Western
(WesternRegion)
Region)
Kamlesh
Kamlesh
C.Patel
Patel
KamleshC.
C.
Patel
(Western
Region)
(Eastern
(EasternRegion)
Region)
Subharthee
Dey
SubhartheeRoy
DeyChowdhury
Deepnath
(Northern
Region)
(NorthernRegion)
Region)
(Eastern
B.R.
Sikri
Sundeep
V.
B.R.
Sikri
Sundeep
V.Bambolkar
Bambolkar
B.
R. SikriRegion)
(Southern
(Southern
Region)
(Northern
Region)
S.
S.V.
V.Veerramani
Veerramani
T.
Ravichandiran
Hon.
General
Secretary
Hon.
General
Secretary
Hon.
General
Secretary
Hon.
General
Secretary
Bal
Kishan
Gupta
(Southern
Region)
Bal
Kishan
Gupta
Bharat
N.
Shah
Bharat N. Shah
Hon.
Hon.
Joint
Secretaries
Hon.
General
Secretary
Hon.
Joint
Secretaries
Hon.Joint
JointSecretaries
Secretaries
Vinod
Kalani
Vinod
Kalani
M.
Mahesh
H. Doshi
M.J.J.Shah
Shah
Pranav
Choksi
Pranav
Choksi
Pranav
Choksi
Pranav
Choksi
Hon.
Joint
Secretaries
Hon.
Treasurer
Hon.
Treasurer
Hon.
Treasurer
Hon.
Treasurer
Mayank
J.
Shah
Mahesh
H.
Mahesh
H.
Doshi
Mahesh
Doshi
MaheshH.
H.Doshi
Doshi
Bhavin
M.
Mehta
For
information
For
information
contact
IDMA
Secretariat:
For
contact
IDMA
Secretariat:
Forinformation
informationcontact
contactIDMA
IDMASecretariat:
Secretariat:
Hon.
Treasurer
Daara
B.
Patel
Daara
B.
Patel
Daara
B.
Patel
Daara B. Patel
Bharat
N. Shah
Secretary-General
Secretary-General
Secretary-General
Secretary-General
T.R.
Gopalakrishnan
T.R.
Gopalakrishnan
For
information
contact IDMA Secretariat:
T.R.
Gopalakrishnan
T.R. Gopalakrishnan
Advisor
Advisor
Daara B. Patel
Prachi
PrachiRane
Rane
Secretary-General
Sr.
Sr.Manager
Manager
(Publications
&&PR)
T.R.
Gopalakrishnan
(Publications
PR)
Deputy
Secretary-General
C.K.S.
Chettiar
C.K.S.
Chettiar
C.K.S.
Chettiar
C.K.S. Chettiar
Asst.
Asst.
Manager
Asst.
Manager
Melvin
Rodrigues
Asst.Manager
Manager
(Publications)
(Publications)
(Publications)
(Publications)
Sr
Manager (Commercial & Administration)
C.K.S. Chettiar
AAPublication
Publicationof
of
AAPublication
Publicationofof
Asst.
Manager
(Publications
& Administration)
Indian
Drug
Manufacturers'
Association
Indian
Drug
Manufacturers'
Association
Indian
Drug
Manufacturers'
Association
Indian
Drug
Manufacturers'
Association
102-B, 'A-Wing', Poonam Chambers
102-B,'A-Wing',
'A-Wing',Poonam
PoonamChambers
Chambers
102-B,
A Publication
ofChambers
102-B,Road,
'A-Wing',
Poonam
Dr.
Dr.A.B.
A.B. Road,Worli,
Worli,Mumbai
Mumbai--400
400018
018
Tel
::022-2494
4624
/
2497
4308
Fax:
022-2495
0723
Tel
022-2494
4624
/
2497
4308
Fax:
022-2495
0723
102-B, 'A-Wing', Poonam
Chambers
e-mail:
/ /[email protected]
e-mail:[email protected]
[email protected]
[email protected]
e-mail:
/ /[email protected]
e-mail:[email protected]
[email protected]
[email protected]
Dr.Website:
A.B.
Road,www.idma-assn.org
Worli,
Mumbai
- 400 018
Website:
www.idma-assn.org
Website:
Website:
www.idma-assn.org
Tel : 022-2494
4624 /www.idma-assn.org
2497 4308
Fax: 022-2495
0723
Published
on
Published
on7th,
7th,14th,
14th,21st
21stand
and30th
30thof
ofevery
everymonth
month
Published
e-mail:
mail_on
[email protected]/[email protected]
Published
on7th,
7th,14th,
14th,21st
21stand
and30th
30thofofevery
everymonth
month
Dr.
Road,
Worli,
Mumbai
--400
Dr.A.B.
A.B.4624
Road,
Worli,
MumbaiAssociation
400018
018
Indian
Drug
Manufacturers'
Tel
::022-2494
/ /2497
Tel
022-2494
4624
24974308
4308Fax:
Fax:022-2495
022-24950723
0723
Website: www.idma-assn.org
Annual
AnnualSubscription
Subscription
Published on 7th, 14th, 21st and 30th of every month
````1000/1000/only
(for
IDMA
members)
1000/only
(for
IDMA
members)
1000/-only
only(for
(forIDMA
IDMAmembers)
members)
Annual
Subscription
3000/only
(for
non-members)
3000/only(for
(fornon-members)
non-members)
````3000/only
3000/only
(for
non-members)
US$
300
(Overseas)
` 1000/(for
IDMA
members)
US$300
300(Overseas)
(Overseas)
US$
US$
300
(Overseas)
Please
send
your
payment
inin
favour
ofof
` 2000/(for
Government
Research/
Please
send
your
payment
favourof
Please
send
your
payment
favour
Please send your paymentinin
favour
of
Educational
Institutions)
Indian
Drug
Manufacturers'
Association
Indian
Drug
Manufacturers'
Association
Indian
Manufacturers'
Association
Indian`Drug
Drug
Manufacturers'
Association
4000/(for non-members)
US$ 400 (Overseas)
OPINIONS
EXPRESSED
OPINIONS
EXPRESSEDBY
BYTHE
THEAUTHORS
AUTHORSOF
OF
Please send your payment in favour of
INDIVIDUAL
ARTICLES
DO
NECESSARILY
INDIVIDUAL
ARTICLES
DONOT
NOT
NECESSARILY
Indian Drug Manufacturers'
Association
Issue No.
No. 48
Issue
22
Issue No. 29
29
22
22 01
to 30
December
2014
to
07
August
June
2013
0108
toto
0714
August
2012
08
to
14
June2012
2013
IDMA ACTIVITIES:
ADVISORY
TO MEMBERS
IDMA
ACTIVITIES
: : ::
IDMA
ACTIVITIES
IDMA
ACTIVITIES
IDMA
ACTIVITIES
API
China
2014
and 5th Sino-India Forum: A Brief Report & Glimpses.................8
SLA-Approved
FDCs
–onSubmission
of––data
..........................................................................7
Drugs
(Prices
Control)
Order
2013
Urgent
Issues:
IDMA
.................4
IDMA
Representation
Unfair
Limitation
Criteria
imposed
on
SSI
units
..........................
14
Drugs
(Prices
Control)
2013
Urgent
Issues:
IDMA
representation
.................4
IDMA
Representation
Unfair
Limitation
imposed
onrepresentation
SSI
unitsand
..........................
14
• Presentations on
onOrder
“Status
Quo
ofCriteria
Chinese
Generic
Drugs
GOVERNMENT
NOTIFICATION
: ::
GOVERNMENT
NOTIFICATIONS
GOVERNMENT
NOTIFICATIONS
Business
Opportunities
in the future”: by Mr Zhang Mingyu .........................9
SERVICE
TAX
::
SERVICE
TAXCIRCULAR
CIRCULAR
Pioglitazone
suspension
revoked
with
conditions-reg.
..........................................................8
Ban
Dextropropoxyphene
for
human
................................................................5
Banon
onInteractive
Dextropropoxyphene
for
human
use
................................................................5
IDMA
Meeting
with
Ernst
&use
Young
LLP and
on
effect of related
GST
on
Draft
Circular
on
leviability
of
service
staff
employment
Draft
Circular
on
leviability
of
service
taxon
on
staffbenefits
benefits
andthe
employment
related
GOVERNMENT
COMMUNICATION
: tax
FDA
COMMUNICATIONS
:
FDA
COMMUNICATIONS
:
Pharmaceutical
Manufacturers.
.
..........................................................................13
transactionsreg
...............................................................................................................16
rd
transactionsreg ...............................................................................................................16
Record
of Discussion
of
3 Meeting
of the BHLG on Trade with Mexico-reg. ......................9
Drug
Control)
Order,
1995
Drug(Price
(Price
Control)
Order,
1995.................................................................................6
.................................................................................6
IDMA
delegation
meets
IPR
::
CENTRAL
EXCISE
MATTERS
: Shri J P Nadda, Hon’ble Minister for
IPRMATTERS
MATTERS
IPR:
IPR:
Health
&
Family
Welfare.
.
....................................................................................13
Re-printing,
re-labeling,
re-packing
or stickering
Scheduled formulations in
Intellectual
Property
Rights
ininPharma
Industry
...............................................................
18
Intellectual
Property
Rights
Pharma
Industry: :of
...............................................................
18
IPR
...........................................................................................................6
IPRNotifications
Notifications
...........................................................................................................6
GOVERNMENT
pursuance
of the COMMUNICATIONS:
provisions
under the: DPCO 2013 exempted from CED-reg. ....................9
DRUGS
&
COSMETICS
NOTIFICATIONS
DRUGS
& COSMETICS
NOTIFICATIONS
:
Draft
Rules
to
amend
the
Patents
Rules,
2003
published
–
reg.
.................................7
DraftMATTERS
Rules
to: amend
the Patents Rules,
2003 published
–(UCPMP)
reg. .................................7
DGFT
Uniform
Code
of Pharmaceuticals
Marketing
PracticesTrials
– reg.............15
Drugs
&&Cosmetics
(3rd
DrugsMATTERS
Cosmetics
(3rdAmendment)
Amendment)for
forconducting
conductingClinical
Clinical Trials––
DGFT
::NOTIFICATIONS:
DGFT
MATTERS
Inclusion
of
Kattupalli
Sea
Port
as
a
Port
of
Registration
under
Para
4.19
of
HBP .............10
GOVERNMENT
Draft
DraftRules
Rules2012
2012––reg.
reg. ....................................................................................................27
....................................................................................................27
Online
and
issue
Certificatesfor
export
ofof
Inviting
suggestions
to
prevent
unintended
benefit
under Incremental
Onlineapplication
application
and
issueof
ofRegistration
Registration
Certificatesfor
exportExport
Drugs
&
Cosmetics
Notification:
Compensation
Drugs
&
Cosmetics
(4th
Amendment)
for
Registration
of
Ethics
Committee
stst Registration of Ethics Committee
Drugs
&commodities
Cosmetics
(4th
Amendment)
various
effective
from
July,
2013-reg.
Incentivisation
Scheme-reg.
................................................................................................11
various
commodities
effective
from11for
July,............................................................22
2013-reg...............................................15
..............................................15
in
cases
ofRules
Clinical
Trial
incidents
– reg.
(EC)
––Draft
––reg.
............................................................................................28
(EC)
Draft
Rules2012
2012
reg.
............................................................................................28
Amendment
in
Para
2.35(b)
of
FTP,
2009-2014-reg.
................................................16
Amendments
in
the
Reward/Incentive
Schemes
of Chapter
3 of FTP
Amendment
in
Para
2.35(b)
of
FTP,
2009-2014-reg.
................................................16
CENTRAL
EXCISE Matters:
Drugs
(4th
Rules
2012
––I)-reg.
reg.....................................................
31
Drugs&&Cosmetics
(4thAmendment)
Amendment)
Rules
2012
reg.....................................................
31
2009-14
-Cosmetics
Appendix
37D
ofPara
HBP
of
Procedure
(Vol.
.................................................11
Notification
ofofIran
ofofFTP,
2009-2014-reg.
.................................16
Notification
Iranunder
under
Para2.35(b)
2.35(b)
FTP,
2009-2014-reg.
.................................16
Amendment
to CESTAT
CUSTOMS
NOTIFICATION
: : Appeal Forms – reg. ...................................................25
CUSTOMS
NOTIFICATION
INTERVIEW
:
CORPORATE
CORPORATEAFFAIRS
AFFAIRSMATTERS:
MATTERS:
Inclusion
of cases
filed
in exchange
the
Settlement
Commission
in the
“Call-Book” - ...............13
reg........30
CBEC
Custom
new
rates
from
Indian
Pharma
market
needs
strong
regulatory
set-up
: Kiran
Mazumdar-Shaw
CBECnotifies
notifies
Custom
new
exchange
ratesvalid
valid
from
Power
of
ROCs
totoobtain
declaration/affidavits
from
Power
of
ROCs
obtain
declaration/affidavits
fromsubscribers/first
subscribers/first
02.08.2012
–Matters:
reg.
...............................................................................................................33
customs
02.08.2012
–
reg.
...............................................................................................................33
IPR
MATTERS
:
directors
directorsatatthe
thetime
timeofofincorporation-reg.
incorporation-reg....................................................................17
...................................................................17
NATIONAL
NEWS
India
asks
US
to: :tighten
patent
regime
to curb in
misuse
: Amiti
Norms
for
Execution
Bank
Guarantee
respect
of Sen .....................................14
NATIONAL
CUSTOMS
MATTERS
:: of
CUSTOMSNEWS
MATTERS
NATIONAL
NEWS
: medicine
AdvanceLicense/EPCG
Schemes
–
reg..
.
...........................................................31
Union
Govt’s
free
Policy
to
boost
generic
drug
sales:
Deloitte’s
Director
Union
Govt’s
free
medicine
Policy
to
boost
generic
drug
sales:
Deloitte’s
Director............
............34
34
24x7
Customs
Operation
atatMajor
and
Airports ––reg.
24x7of
Customs
Operation
MajorPorts
Ports
and
reg.......................................17
......................................17
Drug
war: Centre
against
companies’
move
to Airports
sellGoa
old stocks
at
above-ceiling
rates .....15
Re-warehousing
of
goods
imported
and/or
procured
GPMA
urges
DCGI
to
expedite
process
of
notifying
Port
for
import
...........................
34
GPMA
urges
DCGI
to
expedite
process
of
notifying
Goa
Port
for
import
...........................
34
Customs
permission
for
transhipment
of
goods/containers
from
a
Customs
for
transhipment
ofbranded
goods/containers
from a
Lupin’s
newpermission
CEO
eyes
more
revenue from
drugs.................................................16
indigenously
by
EOU/EHTP/STP/BTP
units
-..............................................................
reg...............................................31
Scarce
rains
hit
Pharma
cos’
seasonal
drug
sales
..............................................................
35
Gateway
Port
to
a
CFS
of
another
CS
reg.
..............................................................18
Scarce
rains
hit
Pharma
cos’
seasonal
drug
sales
35
Gateway
Port
to
a
CFS
of
another
CS
reg.
..............................................................18
Revised drug prices: Pharma bodies challenge Govt fiat ....................................................16
Authentication
of
supply
invoice/ARE-3
by
the CE
CBEC
Madurai,
inincontrols
Tamil
Nadu
for
..................................................19
Committee
backs
retaining
on
ininCFS-reg.
Pharma
36
Confusion
over
deadline
to
revise
prices
....................................................................17
CBECnotifies
notifies
Madurai,
Tamildrug
Nadu
for
CFS-reg.
..................................................19
Committee
backs
retaining
controls
onFDI
FDI
Pharma.......................................................
.......................................................
36
th
Authorities
for
claiming
Deemed
export
benefits
-7reg..
.......................................32
New
Pharma
Policy
alone
can’t
make
healthcare
affordable
..............................................18
CBEC
notifies
New
Exchange
Rate
with
effect
from
2013
Health
more
drugs
for
Compulsory
CBECMinistry
notifiesidentifying
New Exchange
Rate with
effect
from
7thJune
June
2013--reg.
reg...................20
..................20
Health
Ministry
identifying
moreessential
essential
drugs
for
Compulsory
CBEC
notifies
Corrigendum
in
respect
rate..........................................................18
of Exchange - reg......................32
Temporary
drug
likely
DPCO of
in force
Licence
as
still
on
..........................................................................................36
INTERVIEW
:debate
Licence
asdebate
stillrages
rages
ononce
..........................................................................................36
INTERVIEW
: shortage
th Pricing Order ................................19
No
Excise
Duty
on
re-labelling
of generic
drugs
todrug
comply
with
Dec.
2014
- reg........................33
CBEC
notifies
New
Exchange
Rates
w.e.f.
19
India
Health
Progress
terms
free
programme
as
critically
important
..............
37
We
Examining
US
Court’s
on
issue
-critically
Desiraju
...........21
India
Health
Progress
terms
freedecision
generic
drug
programme
as
important
..............
37
Weare
are
Examining
US
Court’s
decision
onRanbaxy
Ranbaxy
issue
-Keshav
Keshav
Desiraju
...........21
Drug
industry
still confused, despite directive on re-labelling prices ...................................19
NEW
DEVELOPMENTS:
WHO
Prequalified
List
has
more
Generic
Drugs
from
India
than
any
Regulator
turns
down
Pharma
firms’
request
for
hike
inininsulin
price..................................
38
WHO
Prequalified
List
has
more
Generic
Drugs
from
India
than
any
Regulator
turns
down
Pharma
firms’
request
for
hike
insulin
price..................................
38
New drug pricing order challenged in Court ........................................................................20
other
country
--suspension
Nata
Menabde
....................................................................................22
Gujarat
girl designs
pain-free
insulin
delivery
system.........................................34
othercontrols
country
Natafor
Menabde
....................................................................................22
Price
ahead
Patented
Drugs.............................................................................
38
Centre
revokes
of manufacturing
and sale
of Pioglitazone ..............................21
Price
controls
ahead
for
Patented
Drugs.............................................................................
38
Americans
won’t
go
Indian
Pharma
because
ofof...........................................34
Drugs
for
Ebola
likely
to45-day
have
an
Indian
connection.
Americans
won’t
goagainst
Indian
Pharma
because
Cipla
gets
interim
relief
deadline
........................................................................21
Pharma
firms
looking
toagainst
pump
in
into
units
Pharma
firms
looking
toon
pump
infunds
funds
intoIndian
Indian
unitsmay
mayget
getFIPB
FIPBbreather
breather................
................39
39
Ranbaxy
deeds:
Kevin
Ali,
Merck
Sharp
&&at
Dohme
....................................................23
Ranbaxy
deeds:
Kevin
Ali,
Merck
Sharp
Dohme
....................................................23
Ipca
Labs,
Lekar
Pharma
force
NPPA
to
hike
prices
of
2
formulations ...............................22
Artificial
blood
for
all
groups
developed
DU
lab.
.
.............................................35
Foreign
ForeignInvestment
InvestmentPromotion
PromotionBoard
Boarddefers
defersPharmaceuticals
Pharmaceuticals
NATIONAL
:: ...........................................................................................................40
Analgin
set NEWS
for
comeback?
..................................................................................................22
NATIONAL
NEWS
sector
FDI
IPR
FEATURE:
sector
FDIproposals
proposals
...........................................................................................................40
Drugs
Control
Department
forms
squads
to ensure
fair price
.............................................23
Pharma
firms
may
expand
reach
totoprofit
from
higher
volumes
.................................25
Pharma
firms
may
expand
reach
higher
.................................25
Patented
medicine
and
C
Rfrom
L
Narasimhan.
....................................36
`profit
scheme
totovolumes
Planning
Commission
panelaffordability:
suggests
`100-cr
100-cr
scheme
Planning
Commission
suggests
Govt
wants
to agencies
regulate panel
e-cigarette
astodrug
..........................................................................23
State
trading
may
come
rescue
of
Indian
firms
exporting
totoIran
State
trading
agencies
may
come
to
rescue
of
Indian
firms
exporting
Iran............26
............26
support
extra-mural
research
..............................................................................................40
support
extra-mural
research
..............................................................................................40
NPPA
MATTERS
Govt
discontinues
Annual
Health
Survey ............................................................................24
Commerce
Dept
bats
for
Pharma
exporters
...............................................................26
Commerce
Dept
bats
for
Pharma
exporters
...............................................................26
`
2,000-cr
Pharma
Research
Fund..............................................
41
Exim
Bank
to
implement
2,000-cr
Pharma
Fund..............................................
41
Exim Bank
to fixation
implement
Gujarat
FDCA
gears upofto`New
enforce
new
pricesResearch
for first
batch
of
drugs..............................37
Retail
Price
Drug
- DCG(i)'s
approval
- reg.
PCI
totonew
come
down
heavily
on
colleges
which
lack
required
faculty
&&
under
DPCO
from
July in
29
............................................................................................25
PCI
come
down
heavily
on
colleges
which
lack
required
faculty
35-40%
SME
Pharma
units
Baddi
want
to
sell
off
business
35-40%
SME
Pharma
units
in
Baddi
want
to
sell
off
business
NATIONAL NEWS:
infrastructure
for
BBPharm,
MMPharm
Trials
trouble
....................................................................................................................26
infrastructure
for
Pharm,
Pharmcourses
courses............................................................27
............................................................27
given
ain
claims
industry...........................................................................................41
given
achance;
chance;
claims
industry...........................................................................................41
Pharma
companies
face
price
pressure
inup
US market........................................38
Clinical
trial
ofof
untested
drugs
mustplans
be regulated:
SC
.........................................................26
Department
Health
Research
to
set
National
Centre
Department
of
Health
Research
plans
to
set
up
National
Centrefor
for
World
Pharma
Trade
Centre
to
be
set
up
in
AP
..................................................................
42
World Pharma
Trade
to in
beBrownfield
set up in APPharma..............................................39
..................................................................
42
Strong
pitch
banCentre
on
FDI
New
rules
halt for
clinical
trials
by foreign
firms .......................................................................27
Clinical
Pharmacology
................................................................................................28
Clinical
Pharmacology
................................................................................................28
Indian
drug
firms
lobby
against
EU’s
new
directive
.............................................................
42
Indian Jan
drug
firms
lobbyfrom
against
EU’s
new directive
.............................................................
42
Pharma
export
growth
India
declines
with
slow
down
in
US,
From
1,
Pharma
companies
can
no
longer
gift
freebies
to
doctors..............40
CDSCO
initiate
druggists
expose
temperature
CDSCOtoto
initiateaction
actionagainst
against
druggistswho
who
expose
temperature
European
markets,
exporters
seek
government
support
.....................................................28
Govt
takes
call
inintemperature
Pharma
........................................................................................43
Govt
takes
callon
on
FDI
Pharma
........................................................................................43
sensitive
drugs
totoFDI
high
...........................................................................28
‘Pharma
industry
may
create
45k
new
jobs in 2015’: report................................41
sensitive
drugs
high
temperature
...........................................................................28
US FDA asks
Indian
drugmakersto
comply
or IP
face
action ..................................................28
Pharmexcil
asks
Commerce
Ministry
totomake
Pharmexcil
Commerce
Ministry
make
IPrecognized
recognized
Stock
up
drugs,
wholesalers
cutting
supply
...........................................................29
Apex
committee
on
clinical
trials
grants
approval
to 28 proposals......................41
Stock
upon
onasks
drugs,
wholesalers
cutting
supply
...........................................................29
US
regulator
tightens
drug
approval
norms
.........................................................................29
Globally
to
make
Indian
Drugs
cheaper
..............................................................................
44
Globally
to make Indian
Drugs
cheaperto..............................................................................
44
Drug
wholesalers
may
Mumbai
.........................................................30
Glenmark
to strengthen
US
with
more
generic
...................................... 42
Drugexpresses
wholesalers
mayhold
holdpresence
Mumbai
toransom
ransom
.........................................................30
TAC
concern
over
US
attempt
to
curb supply
offilings.
affordable
Price
control
may
hit
Multinational
Pharmas
.......................................................................
45
Price control
may hit
Multinational
Pharmas
.......................................................................
45
generic
medicines
from
India
...............................................................................................30
Apollo
Pharmacy
halts
sale
of
Ranbaxy
drugs
...........................................................30
Apollowarns
Pharmacy
sale of Ranbaxy
India
Egypthalts
companies
against drugs
selling...........................................................30
Sovaldi medicines........................42
Some
key
African
recognition
ofofIndian
Pharmacopoeia
soon
.....
45
AP
relaxes
banGets
oncountries
bulk
drugcontemplating
units’
expansion
.....................................................................31
Some
key
African
countries
contemplating
recognition
Indian
Pharmacopoeia
soon
.....
45
Zydus
Cadila
Controllers
Nod
to
launch
Cholesterol
Drug
...............................31
Zydus Cadila
Gets Controllers
Nod
to launch
Cholesterol
Drug ...............................31
Clinical
trial regulations
to becare
developed
through
consultative
approach............43
Generic
drugs may
cut hepatitis
costControllers
..........................................................................31
Health
Ministry
appoints
55Deputy
Drugs
atbigger
CDSCO
ininDelhi
Health
appoints
Deputy
Drugs
Controllers
CDSCO
Delhi...........................
...........................46
46
Pharma
Exports
slow
weak
saves
cos
hit
Pharma
Exports
slowdown,
down,
weak
cosfrom
fromat
bigger
hit.....................................32
.....................................32
Now,
aMinistry
toll-free
number
to report
medicine
reactions.
.........................................44
FIPB
clears
6 Brownfield
Pharma
FDIsaves
proposals
................................................................31
Drug
shortage
likely
as
chemists
run
on
limited
stock
................................................32
Drug
shortage
likely
as
chemists
run
on
limited
stock
................................................32
FEATURE
Health
ministry
launches
‘Teeka
Express’
to protect children
from
Medical
device
industry
cautions
Government
on FDI........................................44
FEATURE
life-threatening
diseases
......................................................................................................32
Hospitals,
chemists
totowait
for
on
......................................33
Hospitals,
chemists
wait
forregulatory
regulatoryword
word
onRanbaxy
Ranbaxymoves
......................................33
Govt
studying
options
as Novartis-Cipla
patent
dispute
to Court.............45
The
Pill
Pushers
..................................................................................................................47
The
Pill
Pushers
..................................................................................................................47
Govt to revoke ban
on Pioglitazone,
.......................................................................33
INTERNATIONAL
NEWS
::set up techAnalgin
INTERNATIONAL
NEWS
Government
plans
to
park
for
medical
devices
in Gujarat................46
INTERNATIONAL NEWS :
New
Newdrugs
drugsfor
forcancer
cancerenlist
enlistbody’s
body’sdefenses
defenses ............................................................33
............................................................33
IDMA
Calendar
.........................................................................................................15
MHRA
Appoints
New Chief
.................................................................................................34
IDMAEvent
Event
Calendar
.........................................................................................................15
FEATURE
FEATURE
IDMA
53rd::Annual Day Celebrations Announcement, Advt. Tariff,
“Employee
Relations
2012
–
Resurgence
And
Revival”
National
HRM
th
“Employee
Relations
2012
–Convention
Resurgence
And
Revival”(EFI
(EFI
National
HRM
16
Pharmaceutical
Analysts’
......................................................................................
4
Shortages
ofofDrugs
threaten
TB
fight
.........................................................................35
Advt.
Booking
form,
Registration
and
Programme
details
etc..................................4
Shortages
Drugs
threaten
TBform
fight
.........................................................................35
nd
Relations
Conference)
............................................
Summit
––2012
&&won
CIE
32
Employee
Relations
Conference)
............................................26
26
Summit
2012
CIE“e-INDIA
32ndEmployee
FDCA,
Gujarat
has
Health
Award
2013
for
XLN
..................................................
34
IDMA
Event Calendar 2014-15........................................................................................24
nd
Invitation
for
bids
ACT
Combi
Packs
&&Capsule
Miltefosine
.....................38
IDMA-APA
Guideline
technical
monographs
32
National
Conference
on available
“Governance,
Risk
Management
&................................................
Compliance”
(GRC)..................
35
2IDMA-APA
Invitation
for
bidsfor
fornow
ACT
CombiBlister
Blister
Packs
Capsule
Miltefosine
.....................38
Guideline
now
available
technical
monographs
................................................
32
Idma
Holidays for the Year 2015........................................................................46
th
APA-PAC
2013
Awards
................................................................................................
36
16
EFI
National
Award
Excellence
ininEmployee
EFIIDMA
National
Award
for
Excellence
EmployeeRelations-2013
Relations-2013...............................39
...............................39
Available
DVD
ofofIP
2010
.................................................................................................49
Available
DVD
IP–Card.................................................................................................48
–for
2010
.................................................................................................49
REPRESENT
REPRESENTTHE
THEOFFICIAL
OFFICIALVIEW
VIEWOF
OFIDMA.
IDMA.
IDMA
Tariff
thth
IDMA -Bulletin
Quality
Excellence
Awards
2013
.......................................................................................
37
Seminar
on
Barcode
at
2.00
p.m.
on
26
June
2013
at
Mumbai
...............................40
Seminar
on Barcode
at 2.00 p.m.
on 26 June 2013 at Mumbai ...............................40
OPINIONS EXPRESSED BY THE AUTHORS OF
IDMA
Publications
...............................................................................................................51
nd
TM
Publications
...............................................................................................................51
Exhibition
- PharmaTech
Expo
.................................................................................... 3933
2IDMA
IDMA
Bulletin
Subscription
Form.
.2013
...................................................................................49
IDMA
Bulletin
XLIII
01
to
07
IDMA
BulletinARTICLES
XLIII(29)
(29)
01
toNECESSARILY
07August
August2012
2012
IDMA
Event
Calendar
2013
........................................................................................39
INDIVIDUAL
DO
NOT
IDMA Event Calendar 2013 ........................................................................................39
nd
REPRESENT
THE
OFFICIAL
OF
IDMA.
Advertisements
.......................................................................................................
2,50
41,to43-48
(29)
01
07
August
20132Advertisements
IDMA
Bulletin
(22)
to
June
2013
Pharmaceutical
Seminar
IDMA
BulletinXLIV
XLIV
(22)08
08VIEW
to14
14
June
2013
2ndIndia–Japan
India–Japan
Pharmaceutical
Seminar/ /Business
BusinessMatching
MatchingInInOsaka
Osaka..................44
..................44
. ....................................................................................2,
5233
IDMA Bulletin XLIV
XLV (48)
(38)22
08to
to30
14December
October 2013
2014
3
Advertisements
Advertisements....................................................................................................2,
....................................................................................................2,46-52
46-52